Replies to post #15187 on Guided Therapeutics Inc (GTHP)

[myjo]

As per USFDA’s laws about clinical trials‘ information disclosure and SEC’s Rules and Regulations about clinical trials’ information disclosure : FDAAA801 42 CFR Part 11 Section 223, 208(b)(1), 107(a)(2), section 552 of Title 5 United States Code And as per SEC Rule SEC CFR 45, 43 Part 11; GTHP & Gene “should” have disclosed medical sites’ information and at what stage each site is; to stockholders. Which they haven’t done it yet, in spite of repeatedly asking to disclose that information to stockholders. Hopefully SEC’s enforcement attorneys will look into this as a possible violation of laws.
Plus there are many more which I don’t want to discuss here.

[GetSeriousOK]

Every publicly traded biotech hides behind Safe Harbor statements.

"Absolutely nothing has materialised yet?" LOL, be sure to tell that to the SEC enforcement attorneys. But don't let them find the Protocol, the S-1, or this web page:

https://clinicaltrials.gov/ct2/show/study/NCT04915495